Experience of the Implementation of Rapid On-Site Evaluation in Ultrasound-Guided Fine-Needle Aspiration Biopsy of Thyroid Nodules

Chamorro, Flor Marina Medina; Calle, José Abella; Stein, Juliana Escobar; Merchancano, Lina; Briñez, Andrés Mauricio Mendoza; Wilches, Andrés Arturo Pulido

doi:10.1067/j.cpradiol.2017.06.009

Cited by 16 publications

(17 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…US-FNA is the most commonly available way to evaluate thyroid nodules, however obtaining inadequate samples remain one of the challenging aspects of this procedure with rates up to 40% reported in the literature [7] Ideally, non-diagnostic samples should not exceed 10% [8]. ROSE was suggested to improve the adequacy rate of obtained samples.…”

Section: Discussionmentioning

confidence: 99%

“…When tissue sampling is required, ultrasound guided fine needle aspiration [US-FNA] represents an easy and effective way of getting the needed tissue with minimal risk [5]. Despite the use of ultrasound to guide our choice for biopsy site, obtaining inadequate sample for diagnosis has been one of the most frustrating consequences of this procedure, mainly due to obtaining few or no cells which is reported to occur in 10-40% of cases [6,7]. This can result in many cases in repeating the procedure which subsequently contributes towards increasing cost and patient anxiety; it can also lead to treatment delay [8].…”

Section: Introductionmentioning

confidence: 99%

“…Rapid On-Site Evaluation (ROSE) of the obtained sample was proposed to determine the presence of adequate cells in the obtained specimen. Multiple studies around the world has demonstrated beneficial effect of this strategy in decreasing the rate of inadequate specimen with US-FNA at multiple sites, including thyroid [7,[9][10][11][12]. Some even suggested using tele-cytopathology to overcome the shortage of onsite cytopathologist at some sites [13].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Rapid On-site Evaluation (ROSE) for Fine Needle Aspiration of Thyroid: Is It Helpful?

et al. 2021

View full text Add to dashboard Cite

Introduction: Thyroid nodules are very common. Many are detected incidentally due to increased head and neck imaging. The majority are benign; however, malignancy can’t be excluded in many cases and tissue sampling is needed. Ultrasound guided fine needle aspiration is an easy and effective way to sample g thyroid nodules. Inadequate sampling was reported in 10-40% of the cases. Rapid On-site Evaluation (ROSE) was proposed to assess obtained sample for adequacy. The aim of this study is to identify the benefit of applying ROSE with US-FNA of thyroid nodules within our institution. Materials and methods: Patients who underwent FNA for thyroid nodules with ROSE availability documented in their procedure note between January 2017 to December 2018 were retrospectively included. All procedures were done by experienced radiologists. Aspirated material was Diff Quik stained for immediate evaluation. The final cytological diagnosis and specimen adequacy was based on The Bethesda system for reporting thyroid cytopathology. Specimen adequacy was compared between ROSE and non-ROSE groups. Results: 442 thyroid nodules were biopsied. ROSE was available for 65 nodules. Non-diagnostic rate with ROSE was 10.8% compared to 13.8% without ROSE with the difference being statistically insignificant. ROSE availability improved sample adequacy of nodules less than 3 cm with statistically significant difference of 100.0% with ROSE vs. 87% without ROSE. Conclusion: The current study does not justify the routine use of ROSE. However, ROSE availability is beneficial with smaller sized thyroid nodules and less experienced radiologists performing the procedure. Doi: 10.28991/SciMedJ-2021-0301-1 Full Text: PDF

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Rapid On-site Evaluation (ROSE) for Fine Needle Aspiration of Thyroid: Is It Helpful?

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The carcinoma was found in the dominant nodule measuring 3.5 cm which underwent FNAB two times. The rate of nondiagnostic (TBSRTC I) FNABs has been reported between 2-34% in the literature 14 . Ultrasound guidance and on-site evaluation of the specimen for adequacy was strongly recommended to decrease the percentage of unsatisfactory biopsies 14 .…”

Section: Discussionmentioning

confidence: 99%

“…The rate of nondiagnostic (TBSRTC I) FNABs has been reported between 2-34% in the literature 14 . Ultrasound guidance and on-site evaluation of the specimen for adequacy was strongly recommended to decrease the percentage of unsatisfactory biopsies 14 . In our institution we routinely perform FNAB under ultrasound guidance, but on-site evaluation is not performed.…”

Section: Discussionmentioning

confidence: 99%

Comparison of the Bethesda system classification and postoperative cytology of thyroid nodules: A single center experience

Özdenkaya¹,

Ersavas²,

Ölmüşçelik³

et al. 2019

Dicle Tıp Dergisi

View full text Add to dashboard Cite

Objective: Recent American Thyroid Association Guideline emphasizes that identifying the institutional malignancy risks for each Bethesda category is mandatory to achieve more accurate preoperative diagnosis in thyroid nodules. Aim of this study is to compare the preoperative fine needle aspiration biopsy (FNAB) and postoperative pathology results in a single institution in the era of the Bethesda System for Reporting thyroid Cytology (TBSRTC). Methods: The data of the patients who underwent FNAB and thyroidectomy between 2012 and 2018 were collected retrospectively. Patients who had available TBSRTC classification were included in the study. The malignancy risk of each TBSRTC classification was calculated. Results: One-hundred and forty-five patients were included. The mean age was 45.9±13.6. Preoperative FNAB categorization was TBSRTC I in 3 (2.1%) patients, TBSRTC II in 47 (32.4%) patients, TBSRTC III 16 (11%) patients, TBSRTC IV in 14 (9.7%) patients, TBSRTC V in 29 (20%) and VI in 36 (24.8%) patients. Postoperative pathology revealed malignancy in 66 (45.5%) of the patients. The malignancy risk was 33.3% in TBSRTC I, 4.3% in TBSRTC II, 31.3% in TBSRTC III, 42.9% in TBSRTC IV, 62.1% in TBSRTC V and 94.4% in TBSRTC VI categories. Conclusion: Our results were conformable with the malignancy risks reported by TBSRTC. Larger studies should be performed to validate and endorse nationwide standardization of the Bethesda system.

show abstract

Rapid On-Site Evaluation (ROSE)

Jing,

Kakudo,

Michael

2023

Thyroid FNA Cytology

View full text Add to dashboard Cite

Experience of the Implementation of Rapid On-Site Evaluation in Ultrasound-Guided Fine-Needle Aspiration Biopsy of Thyroid Nodules

Cited by 16 publications

References 17 publications

Rapid On-site Evaluation (ROSE) for Fine Needle Aspiration of Thyroid: Is It Helpful?

Rapid On-site Evaluation (ROSE) for Fine Needle Aspiration of Thyroid: Is It Helpful?

Comparison of the Bethesda system classification and postoperative cytology of thyroid nodules: A single center experience

Rapid On-Site Evaluation (ROSE)

Contact Info

Product

Resources

About